Resources
Manuscripts & Publications
FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein
Erica Simmons, Tohti Amet, Sanofar J. Abdeen, James W. Van Huysse, Ronald R. Bowsher
New BioTechnology 2021
Recommendations for the Development and Validation of Immunogenicity Assays in Support of Biosimilar Programs
Francesca Civoli,1,15 Aparna Kasinath,2 Xiao-Yan Cai,3 Meenu Wadhwa,4 Andrew Exley,5 Philip Oldfield,6
Safa Alvandkouhi,7 Gregor Schaffar,8 John Chappell,9 Ronald Bowsher,10 Viswanath Devanarayan,11
Joseph Marini,12 Shannon Rebarchak,12 Michael Anderson,13 Vera Koppenburg,14 and Todd Lester7
AAPS Journal 2020
Purification, characterization and identification of rat brain cytosolic tyrosine transaminase as glutamine Transaminase-K
Ronald R. Bowshera,∗, David P. Henry
Neurochemistry International 2020
Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-s Reactive Antibodies?
Ronald R. Bowsher1,4 and Viswanath Devanarayan2,3
AAPS Journal October 2020
Similar Immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus
Ronald R. Bowsher
Sun et al. BMC Endocrine Disorders 2021
Immunogenicity of DaxibotulinumtoxinA for Injection in Facial Aesthetic Treatment.
Humphrey S., Dover J.S., Bowsher R.R., Clancy A., Prawdzik G., and Gallagher C.J.
Aesthetic Surgery Journal 2023
Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin
Adam Kinne, Erik Tillman, Sanofar J. Abdeen, Derrick Johnson, Elijah Parmer, Jacob Hurst, Brittany de Temple, Sherri Rinker, Timothy Rolph, Ronald Bowsher
Journal of Pharmaceutical and Biomedical Analysis 2023
Assay development considerations to improve drug tolerance in direct competitive ligand binding neutralizing antibody assays, pretreatment strategies
Alok Rathi, Sherri Rinker, Hongmei Niu, Carina Carter, Seema Kumar, Kyra Cowen
Journal of Immunological Methods 2023
Clinical Immunogenicity of Daxibotulinumtoxin A for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3
Conor J. Gallagher 1,*, Ronald R. Bowsher 2, Amanda Clancy 2, Jeffrey S. Dover 3, Shannon Humphrey 4, Yan Liu 1 and Gregg Prawdzik 1
Toxins 2023
Critical reagent inventory management system and web portal specifically optimized for supporting external clients
Jessica A Feauto, Aleks Davis, Sanofar J Abdeen, Hannah N Gill, Jamie E Colwell, Michael Chiappetta, Ronald R Bowsher
Bioanalysis 2022
Immunogenicity Manuscript: “An Integrated Analysis of Dostarlimab Immunogenicity”
Sharon Lu, Ronald R. Bowsher, Amanda Clancy, Amy Rosen, Mingxuan Zhang, Ying Yang, Kathleen Koeck, Minggeng Gao, Elizabeth Potocka, Wei Guo, Kai Yu Jen, Ellie Im & Ashley Milton
AAPS Journal 2021
Sensitive assay design for detection of anti-drug antibodies to biotherapeutics that lack an immunoglobulin Fc domain
Derrick Johnson, Erica Simmons, Sanofar Abdeen, Adam Kinne, Elijah Parmer, Sherri Rinker, Jennifer Thystrup, Swarna Ramaswamy & Ronald R. Bowsher
Nature Scientific Report 2021